AKT1 and neoplasm: In tumor cells and primary embryonic fibroblasts, Spry2 increases the amount of PTEN and decreases its phosphorylation, thereby enhancing the activity of PTEN to suppress phosphorylation of Akt (Edwin et al., 2006; Feng et al., 2011).